These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26666938)
1. Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients. Poignant S; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F Antimicrob Agents Chemother; 2015 Dec; 60(3):1883-7. PubMed ID: 26666938 [TBL] [Abstract][Full Text] [Related]
2. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF; J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492 [TBL] [Abstract][Full Text] [Related]
3. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis. Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051 [TBL] [Abstract][Full Text] [Related]
4. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital. Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402 [TBL] [Abstract][Full Text] [Related]
5. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. Bar-Yoseph H; Hussein K; Braun E; Paul M J Antimicrob Chemother; 2016 Oct; 71(10):2729-39. PubMed ID: 27317444 [TBL] [Abstract][Full Text] [Related]
7. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Goodman KE; Simner PJ; Tamma PD; Milstone AM Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959 [TBL] [Abstract][Full Text] [Related]
8. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage. van den Bunt G; Liakopoulos A; Mevius DJ; Geurts Y; Fluit AC; Bonten MJ; Mughini-Gras L; van Pelt W J Antimicrob Chemother; 2017 Feb; 72(2):589-595. PubMed ID: 27789683 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization. Vodovar D; Marcadé G; Rousseau H; Raskine L; Vicaut E; Deye N; Baud FJ; Mégarbane B Infection; 2014 Aug; 42(4):743-8. PubMed ID: 24728816 [TBL] [Abstract][Full Text] [Related]
10. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome. Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948 [TBL] [Abstract][Full Text] [Related]
11. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis. Detsis M; Karanika S; Mylonakis E Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141 [TBL] [Abstract][Full Text] [Related]
12. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams? Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641 [No Abstract] [Full Text] [Related]
13. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978 [TBL] [Abstract][Full Text] [Related]
17. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future? Oteo J; Miró E; Pérez-Vázquez M; Navarro F Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048 [TBL] [Abstract][Full Text] [Related]
18. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions. Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997 [TBL] [Abstract][Full Text] [Related]
19. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India. Datta P; Gupta V; Singla N; Chander J Indian J Med Microbiol; 2015; 33(4):612-3. PubMed ID: 26470985 [No Abstract] [Full Text] [Related]
20. [Fecal carriage of third-generation cephalosporins-resistant Enterobacteriaceae in asymptomatic young adults: evolution between 1999 and 2009]. Janvier F; Mérens A; Delaune D; Soler C; Cavallo JD Pathol Biol (Paris); 2011 Apr; 59(2):97-101. PubMed ID: 20828938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]